BP-1210

N/A

Report date: 2022/05/10 11:41:01

Base Information

Drug NameBP-1210

Drug Alias NameBP1210

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionT lymphocytes stimulantsHepatitis A virus cellular receptor 2 inhibitorsAntibody-dependent cell-mediated cytotoxicity (ADCC) effects

TargetsHepatitis A virus cellular receptor 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBrightpath Biotherapeutics Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBrightpath Biotherapeutics Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A